Developer docs
API playgroundTry for free, no card

Search company profiles

Labor Dr. Wisplinghoff

Full company profile

uuid000n382

Namestring
Labor Dr. Wisplinghoff
Legal namestring
Labor Dr. Wisplinghoff, überörtliche Berufsausübungsgemeinschaft Dres. med. Wisplinghoff und Kollegen und Medizinisches Versorgungszentrum für Humangenetik und Transfusionsmedizin GbR
Websiteurl
wisplinghoff.de
Company typeenum
Private
Founded yearint
1978
Descriptiontext

Labor Dr. Wisplinghoff is a physician- and family-owned German medical diagnostic laboratory headquartered in Cologne and operating across 8 sites (Aachen, Berlin, Bonn, Delmenhorst, Frankfurt, Herne, Kempen, Schwäbisch Gmünd). Founded in 1978, the practice is organized as a GbR partnership led by three Wisplinghoff family physicians (Dr. Kurt Peter Wisplinghoff, Prof. Dr. Hilmar Wisplinghoff, and Dr. Fabian Wisplinghoff, MBA) and runs 24/7 with over 60 specialist physicians (Fachärztinnen und -ärzte) covering laboratory medicine, pathology, transfusion medicine, and human genetics. Its service portfolio spans routine clinical chemistry, hematology, immunology, serology, microbiology, and endocrinology, alongside higher-margin specialty diagnostics including NGS-based cardiogenetics and neurogenetics panels, prenatal and postnatal cytogenetics (FISH, microarray-CGH, karyotyping), tumor genetics and molecular pathology (EGFR, KRAS, BRAF, ALK, MSI), pharmacogenetics, hemato-oncology molecular monitoring, and the FDA-approved UroVysion FISH urine test for bladder cancer recurrence.

Technology is centered on validated molecular and cytogenetic platforms — PCR, FISH, next-generation sequencing, Array-CGH, and capillary electrophoresis — supported by an in-house courier sample-pickup network and the Order-Entry/LabMessenger physician integration platform for electronic test ordering and digital result transmission. Direct patient channels include the Mein Befund online results portal (meinbefund.de), the MPU driving-fitness assessment portal (mpu.wisplinghoff.de), and a set of specialized outpatient clinics (coagulation, infectious disease, environmental medicine, genetic counseling). The lab is DAkkS-accredited under DIN EN ISO/IEC 15189, is an IFCC member, and holds TÜV Rheinland certification.

The business operates two parallel revenue streams. The dominant B2B stream is fee-for-service laboratory diagnostics billed to medical practices, hospitals, and clinics through German statutory (GKV) and private (PKV) health insurance reimbursement under EBM and GOÄ schedules, with sample logistics handled by the courier fleet. A secondary D2C/IGeL stream monetizes out-of-pocket patient services including NIPT, Stockholm3 prostate cancer screening, MPU drug testing, coagulation consultations, and individual preventive packages. No external investment, parent company, or acquisition history is disclosed.

Short descriptiontext

Labor Dr. Wisplinghoff is a family-owned German medical diagnostic laboratory in Cologne operating 24/7 across 8 sites with 60+ specialist physicians, providing clinical chemistry, pathology, transfusion medicine, and human genetics services to medical practices, hospitals, and direct patients nationwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersKöln, Germany
HQ citystring
Köln
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices9 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical diagnostic services, clinical laboratory medicine, human genetics diagnostics, transfusion medicine services, pathology diagnostics
Industry3 codes
PRIMARYHLAGAEAA
Central Laboratory Services (Core Lab Operations)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAFAMAJ
Reference & Esoteric Testing Laboratories
SECONDARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
NAICS code1 code
  • Medical Laboratories621511
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Medical Diagnostic Laboratory Services
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1B2B Laboratory Diagnostic Services
TypeSubscription Recurring
Description

Laboratory testing services billed to medical practices, clinics, and hospitals. Revenue generated through statutory health insurance (GKV/gesetzliche Krankenversicherung) and private insurance (PKV/privat Krankenversicherung) reimbursement according to EBM and GOÄ fee schedules.

wisplinghoff.de
2Patient-Direct Services (IGeL)
TypeOne Time License
Description

Individual health services offered directly to patients including NIPT (non-invasive prenatal testing), Stockholm3 prostate cancer screening, MPU drug testing, and preventive health packages. Billed privately to patients.

wisplinghoff.de
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Pricing details2 tiers
1Standard laboratory services billed through health insurance
ModelSubscriptionBilling cadencePay-as-you-go
Notes

Services covered by German statutory health insurance (GKV) and private insurance (PKV) according to EBM/GOÄ fee schedules

wisplinghoff.de
2NIPT as IGeL service
ModelOtherBilling cadencePay-as-you-go
Notes

Non-invasive prenatal testing offered as IGeL (Individual Health Service) - price available upon request

wisplinghoff.de
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1Mein Befund
Description

Online patient portal for accessing laboratory results digitally

wisplinghoff.de
+2 more records
Core offering1 text field

Physician- and family-owned medical diagnostic laboratory providing comprehensive clinical laboratory medicine, pathology, transfusion medicine, and human genetics services across 8 locations in Germany. Over 60 specialist physicians operate 24/7 to deliver diagnostic testing to medical practices, hospitals, and clinics, supplemented by direct patient services including NIPT, MPU testing, coagulation consultation, and genetic counseling.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 24/7 laboratory operations ensuring continuous diagnostic availability
+1 more record
Product overview1 text field

Labor Dr. Wisplinghoff is a physician- and family-owned medical diagnostic laboratory offering the full spectrum of laboratory medicine, pathology, transfusion medicine, and human genetics across 8 German locations (Cologne main site plus Aachen, Berlin, Bonn, Delmenhorst, Frankfurt, Herne, Kempen, and Schwäbisch Gmünd). The portfolio centers on four core disciplines — laboratory medicine diagnostics (clinical chemistry, hematology, immunology, microbiology, serology, endocrinology, toxicology), pathology/cytology (including molecular pathology), transfusion medicine/blood depot, and human genetics (molecular genetics, cytogenetics, pharmacogenetics, genetic counseling). These are flanked by specialized add-on services including NIPT (non-invasive prenatal testing, offered since 2015), the Stockholm3 prostate cancer screening test, an MPU portal for driving-ability assessments, the Mein Befund online patient results portal (meinbefund.de), a coagulation outpatient clinic, and an infectious disease private outpatient clinic. The laboratory employs over 60 specialist physicians and operates 24/7. Sample logistics are supported by a laboratory-owned pickup service, and the online Order-Entry system (LabMessenger) enables electronic test ordering by physicians.

Product and service10 records
1Laboratoriumsmedizin (Laboratory Medicine Diagnostics)
CategoryClinical Laboratory Medicine
Description

Core laboratory diagnostics covering clinical chemistry, hematology, coagulation, immunology, serology, endocrinology, microbiology, and infectious disease testing for medical practices and hospitals.

2Pathologie / Zytologie (Pathology / Cytology)
CategoryPathology
Description

Histological and cytological pathology analysis for medical practices and hospitals, including specialized molecular pathology techniques such as UroVysion FISH testing for bladder cancer detection.

3Transfusionsmedizin (Transfusion Medicine / Blood Depot)
CategoryTransfusion Medicine
Description

Transfusion medicine and blood depot services including immunohematology and blood group diagnostics for hospitals and clinics.

4Humangenetik (Human Genetics)
CategoryHuman Genetics
Description

Comprehensive human genetic diagnostics including molecular genetics, cytogenetics, microarray-CGH, and non-invasive prenatal testing (NIPT) for medical practices and patients.

5NIPT (Non-Invasive Prenatal Test)
CategoryPrenatal Diagnostics
Description

Non-invasive prenatal blood test for genetic screening of fetal chromosomal abnormalities, offered directly to pregnant patients.

6Stockholm3-Test
CategoryCancer Screening
Description

Blood-based screening test for early detection of prostate cancer, offered as a specialized diagnostic service.

7MPU (Medizinisch-Psychologische Untersuchung)
CategoryForensic / Driving Ability Assessment
Description

Medizinisch-Psychologische Untersuchung (driving ability assessment) laboratory diagnostics delivered through a dedicated online portal for individuals and assessment centers.

8Gerinnungsambulanz (Coagulation Outpatient Clinic)
CategorySpecialty Consultation
Description

Specialized outpatient consultation service for coagulation disorders and thrombosis patients.

9Humangenetische Beratung (Genetic Counseling)
CategoryGenetic Counseling
Description

Personal genetic counseling service provided to patients on hereditary disease risks, family planning, and diagnostic findings.

10Individuelle Vorsorge / IGeL (Individual Preventive Health Services)
CategoryPreventive Health Services
Description

Individual preventive health services (IGeL-Leistungen) provided directly to patients on a self-pay basis, outside of statutory health insurance coverage.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1NAK (Nationales Antibiotika-Sensitivitätstest-Komitee)
Strategic tierCoreTypeTechnology or Integration
Description

Membership and adherence to EUCAST (European Committee on Antimicrobial Susceptibility Testing) standards for antibiotic sensitivity testing. Provides resistance testing guidelines and antibiotic dosing recommendations for adolescents and adults.

wisplinghoff.de
Strategic tierCoreTypeOthers
Description

Accreditation body providing official recognition of laboratory competence according to DIN EN ISO/IEC 15189 standards

Strategic tierMinorTypeOthers
Description

International professional organization for clinical chemistry and laboratory medicine

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

Europe's largest medical diagnostics provider operating a national network of routine and specialty labs across Germany, directly comparable to Wisplinghoff's full-service B2B and specialty testing model.

TypeDirect peer
Description

Physician-led regional laboratory network in northern Germany offering comparable routine and specialty diagnostics to practices and clinics — the closest mid-sized, physician-owned peer to Wisplinghoff.

TypeDirect peer
Description

Specialty-focused German laboratory group with broad routine and esoteric testing, similar multi-site footprint and B2B/hospital channel mix as Wisplinghoff.

TypeBroad incumbent
Description

Subsidiary of global diagnostics giant Sonic Healthcare, operating multiple German labs (including former Bioscientia) — competes in routine and specialty testing at greater scale.

TypeBroad incumbent
Description

Pan-European diagnostics chain (A.P. Møller Holding) with a presence across multiple European countries including Germany — comparable in offering breadth but with much greater geographic and scale reach.

TypeDirect peer
Description

German specialty lab (part of amedes group) focused on human genetics, reproductive medicine, and gynecology-endocrinology — overlaps directly with Wisplinghoff's NIPT, cytogenetics, and pharmacogenetics services.

TypeBroad incumbent
Description

Hospital-affiliated lab network operated by Helios/Fresenius serving inpatient and outpatient diagnostics — a partial competitor for hospital tenders and clinical chemistry volume.

8Medicover Genetics / GenePlanet
TypeOthers
Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Labor Dr. Wisplinghoff

Medical Diagnostic Laboratory Serviceswisplinghoff.de

Labor Dr. Wisplinghoff is a family-owned German medical diagnostic laboratory in Cologne operating 24/7 across 8 sites with 60+ specialist physicians, providing clinical chemistry, pathology, transfusion medicine, and human genetics services to medical practices, hospitals, and direct patients nationwide.

What Labor Dr. Wisplinghoff does

Labor Dr. Wisplinghoff is a physician- and family-owned German medical diagnostic laboratory headquartered in Cologne and operating across 8 sites (Aachen, Berlin, Bonn, Delmenhorst, Frankfurt, Herne, Kempen, Schwäbisch Gmünd). Founded in 1978, the practice is organized as a GbR partnership led by three Wisplinghoff family physicians (Dr. Kurt Peter Wisplinghoff, Prof. Dr. Hilmar Wisplinghoff, and Dr. Fabian Wisplinghoff, MBA) and runs 24/7 with over 60 specialist physicians (Fachärztinnen und -ärzte) covering laboratory medicine, pathology, transfusion medicine, and human genetics. Its service portfolio spans routine clinical chemistry, hematology, immunology, serology, microbiology, and endocrinology, alongside higher-margin specialty diagnostics including NGS-based cardiogenetics and neurogenetics panels, prenatal and postnatal cytogenetics (FISH, microarray-CGH, karyotyping), tumor genetics and molecular pathology (EGFR, KRAS, BRAF, ALK, MSI), pharmacogenetics, hemato-oncology molecular monitoring, and the FDA-approved UroVysion FISH urine test for bladder cancer recurrence.

Technology is centered on validated molecular and cytogenetic platforms — PCR, FISH, next-generation sequencing, Array-CGH, and capillary electrophoresis — supported by an in-house courier sample-pickup network and the Order-Entry/LabMessenger physician integration platform for electronic test ordering and digital result transmission. Direct patient channels include the Mein Befund online results portal (meinbefund.de), the MPU driving-fitness assessment portal (mpu.wisplinghoff.de), and a set of specialized outpatient clinics (coagulation, infectious disease, environmental medicine, genetic counseling). The lab is DAkkS-accredited under DIN EN ISO/IEC 15189, is an IFCC member, and holds TÜV Rheinland certification.

The business operates two parallel revenue streams. The dominant B2B stream is fee-for-service laboratory diagnostics billed to medical practices, hospitals, and clinics through German statutory (GKV) and private (PKV) health insurance reimbursement under EBM and GOÄ schedules, with sample logistics handled by the courier fleet. A secondary D2C/IGeL stream monetizes out-of-pocket patient services including NIPT, Stockholm3 prostate cancer screening, MPU drug testing, coagulation consultations, and individual preventive packages. No external investment, parent company, or acquisition history is disclosed.

Labor Dr. Wisplinghoff firmographics

Firmographics
Name
Labor Dr. Wisplinghoff
Legal name
Labor Dr. Wisplinghoff, überörtliche Berufsausübungsgemeinschaft Dres. med. Wisplinghoff und Kollegen und Medizinisches Versorgungszentrum für Humangenetik und Transfusionsmedizin GbR
Website
https://wisplinghoff.de
Company type
Private
Founded year
1978
Operating status
Operating
Headcount range
251–500 employees
Short description
Labor Dr. Wisplinghoff is a family-owned German medical diagnostic laboratory in Cologne operating 24/7 across 8 sites with 60+ specialist physicians, providing clinical chemistry, pathology, transfusion medicine, and human genetics services to medical practices, hospitals, and direct patients nationwide.
Ownership category
akta.pro rank

Labor Dr. Wisplinghoff industry classification

Industry
Product category
Medical Diagnostic Laboratory Services
NAICS
Medical Laboratories (621511)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAGAEAA
Central Laboratory Services (Core Lab Operations)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAFAMAJ
Reference & Esoteric Testing Laboratories
SECONDARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories

Keywords

  • Medical diagnostic services
  • Clinical laboratory medicine
  • Human genetics diagnostics
  • Transfusion medicine services
  • Pathology diagnostics

Where Labor Dr. Wisplinghoff is headquartered

Location

Headquarters

HQ city
Köln
HQ country
Germany
HQ region
Europe

Offices9 records

Markets served

Labor Dr. Wisplinghoff business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

  1. B2B Laboratory Diagnostic Services: Laboratory testing services billed to medical practices, clinics, and hospitals. Revenue generated through statutory health insurance (GKV/gesetzliche Krankenversicherung) and private insurance (PKV/privat Krankenversicherung) reimbursement according to EBM and GOÄ fee schedules.
  2. Patient-Direct Services (IGeL): Individual health services offered directly to patients including NIPT (non-invasive prenatal testing), Stockholm3 prostate cancer screening, MPU drug testing, and preventive health packages. Billed privately to patients.

Pricing tiers

ModelBillingPrice
SubscriptionPay-as-you-goStandard laboratory services billed through health insurance
OtherPay-as-you-goNIPT as IGeL service

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Labor Dr. Wisplinghoff product offering

Product offering

Core offering

Physician- and family-owned medical diagnostic laboratory providing comprehensive clinical laboratory medicine, pathology, transfusion medicine, and human genetics services across 8 locations in Germany. Over 60 specialist physicians operate 24/7 to deliver diagnostic testing to medical practices, hospitals, and clinics, supplemented by direct patient services including NIPT, MPU testing, coagulation consultation, and genetic counseling.

Product overview

Labor Dr. Wisplinghoff is a physician- and family-owned medical diagnostic laboratory offering the full spectrum of laboratory medicine, pathology, transfusion medicine, and human genetics across 8 German locations (Cologne main site plus Aachen, Berlin, Bonn, Delmenhorst, Frankfurt, Herne, Kempen, and Schwäbisch Gmünd). The portfolio centers on four core disciplines — laboratory medicine diagnostics (clinical chemistry, hematology, immunology, microbiology, serology, endocrinology, toxicology), pathology/cytology (including molecular pathology), transfusion medicine/blood depot, and human genetics (molecular genetics, cytogenetics, pharmacogenetics, genetic counseling). These are flanked by specialized add-on services including NIPT (non-invasive prenatal testing, offered since 2015), the Stockholm3 prostate cancer screening test, an MPU portal for driving-ability assessments, the Mein Befund online patient results portal (meinbefund.de), a coagulation outpatient clinic, and an infectious disease private outpatient clinic. The laboratory employs over 60 specialist physicians and operates 24/7. Sample logistics are supported by a laboratory-owned pickup service, and the online Order-Entry system (LabMessenger) enables electronic test ordering by physicians.

Differentiator

Problem solved

Functional benefit

Brands

  • Mein Befund: Online patient portal for accessing laboratory results digitally
  • HYGIUM
  • MPU Portal

Products and services

  • Laboratoriumsmedizin (Laboratory Medicine Diagnostics) Core laboratory diagnostics covering clinical chemistry, hematology, coagulation, immunology, serology, endocrinology, microbiology, and infectious disease testing for medical practices and hospitals.
  • Pathologie / Zytologie (Pathology / Cytology) Histological and cytological pathology analysis for medical practices and hospitals, including specialized molecular pathology techniques such as UroVysion FISH testing for bladder cancer detection.
  • Transfusionsmedizin (Transfusion Medicine / Blood Depot) Transfusion medicine and blood depot services including immunohematology and blood group diagnostics for hospitals and clinics.
  • Humangenetik (Human Genetics) Comprehensive human genetic diagnostics including molecular genetics, cytogenetics, microarray-CGH, and non-invasive prenatal testing (NIPT) for medical practices and patients.
  • NIPT (Non-Invasive Prenatal Test) Non-invasive prenatal blood test for genetic screening of fetal chromosomal abnormalities, offered directly to pregnant patients.
  • Stockholm3-Test Blood-based screening test for early detection of prostate cancer, offered as a specialized diagnostic service.
  • MPU (Medizinisch-Psychologische Untersuchung) Medizinisch-Psychologische Untersuchung (driving ability assessment) laboratory diagnostics delivered through a dedicated online portal for individuals and assessment centers.
  • Gerinnungsambulanz (Coagulation Outpatient Clinic) Specialized outpatient consultation service for coagulation disorders and thrombosis patients.
  • Humangenetische Beratung (Genetic Counseling) Personal genetic counseling service provided to patients on hereditary disease risks, family planning, and diagnostic findings.
  • Individuelle Vorsorge / IGeL (Individual Preventive Health Services) Individual preventive health services (IGeL-Leistungen) provided directly to patients on a self-pay basis, outside of statutory health insurance coverage.

Quantifiable outcome

  • 24/7 laboratory operations ensuring continuous diagnostic availability
  • +1 more outcomes

Companies that use Labor Dr. Wisplinghoff

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Labor Dr. Wisplinghoff technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

Labor Dr. Wisplinghoff partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • NAK (Nationales Antibiotika-Sensitivitätstest-Komitee)coreTechnology or IntegrationMembership and adherence to EUCAST (European Committee on Antimicrobial Susceptibility Testing) standards for antibiotic sensitivity testing. Provides resistance testing guidelines and antibiotic dosing recommendations for adolescents and adults.
  • DAkkS (Deutsche Akkreditierungsstelle GmbH)coreOthersAccreditation body providing official recognition of laboratory competence according to DIN EN ISO/IEC 15189 standards
  • IFCC (International Federation of Clinical Chemistry and Laboratory Medicine)minorOthersInternational professional organization for clinical chemistry and laboratory medicine

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Labor Dr. Wisplinghoff competitors and assessment

Company assessment

Direct peers

  • Synlab: Europe's largest medical diagnostics provider operating a national network of routine and specialty labs across Germany, directly comparable to Wisplinghoff's full-service B2B and specialty testing model.
  • LADR Der Laborverbund Dr. Kramer & Kollegen: Physician-led regional laboratory network in northern Germany offering comparable routine and specialty diagnostics to practices and clinics — the closest mid-sized, physician-owned peer to Wisplinghoff.
  • MVZ Labor Limbach: Specialty-focused German laboratory group with broad routine and esoteric testing, similar multi-site footprint and B2B/hospital channel mix as Wisplinghoff.
  • amedes Genetics: German specialty lab (part of amedes group) focused on human genetics, reproductive medicine, and gynecology-endocrinology — overlaps directly with Wisplinghoff's NIPT, cytogenetics, and pharmacogenetics services.

Broad incumbents

  • Sonic Healthcare Germany: Subsidiary of global diagnostics giant Sonic Healthcare, operating multiple German labs (including former Bioscientia) — competes in routine and specialty testing at greater scale.
  • Unilabs: Pan-European diagnostics chain (A.P. Møller Holding) with a presence across multiple European countries including Germany — comparable in offering breadth but with much greater geographic and scale reach.
  • Helios Laboratory Services (Fresenius): Hospital-affiliated lab network operated by Helios/Fresenius serving inpatient and outpatient diagnostics — a partial competitor for hospital tenders and clinical chemistry volume.

Others

  • Medicover Genetics / GenePlanet:

Market position

Strengths3 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Labor Dr. Wisplinghoff social profiles

Digital presence

Labor Dr. Wisplinghoff financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Labor Dr. Wisplinghoff leadership team

Management profile

Number of profiles

Profiles8 records

Labor Dr. Wisplinghoff funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Labor Dr. Wisplinghoff M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Labor Dr. Wisplinghoff

What does Labor Dr. Wisplinghoff do?

Physician- and family-owned medical diagnostic laboratory providing comprehensive clinical laboratory medicine, pathology, transfusion medicine, and human genetics services across 8 locations in Germany. Over 60 specialist physicians operate 24/7 to deliver diagnostic testing to medical practices, hospitals, and clinics, supplemented by direct patient services including NIPT, MPU testing, coagulation consultation, and genetic counseling.

Is Labor Dr. Wisplinghoff a public or private company?

Labor Dr. Wisplinghoff is a private company. It is classified as family owned and is currently operating.

When was Labor Dr. Wisplinghoff founded?

Labor Dr. Wisplinghoff was founded in 1978. It employs 251 to 500 people.

Where is Labor Dr. Wisplinghoff based?

Labor Dr. Wisplinghoff is headquartered in Köln, Germany, in the Europe region.

How does Labor Dr. Wisplinghoff make money?

Two revenue lines are on record. B2B Laboratory Diagnostic Services are the primary driver. The others are patient-Direct Services (IGeL).

Who are Labor Dr. Wisplinghoff's main competitors?

Direct peers on record are Synlab, LADR Der Laborverbund Dr. Kramer & Kollegen, MVZ Labor Limbach and amedes Genetics. Broad incumbents are Sonic Healthcare Germany, Unilabs and Helios Laboratory Services (Fresenius). Medicover Genetics / GenePlanet is listed as an others.

Does Labor Dr. Wisplinghoff have an API?

No public API is recorded for Labor Dr. Wisplinghoff.

What industry is Labor Dr. Wisplinghoff in?

Labor Dr. Wisplinghoff's product category is Medical Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAGAEAA, Central Laboratory Services (Core Lab Operations), with a secondary code of HLAFAMAJ, Reference & Esoteric Testing Laboratories. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooLabor Dr. Wisplinghoff and Genomic Testing Cooperative (GTC) Partner to Deploy GTC’s Comprehensive Suite of Tissue and Liquid Biopsy Testing for Solid Tumor and Hematologic Neoplasms in GermanyLabor Dr. Wisplinghoff and Genomic Testing Cooperative (GTC) announced a partnership to deploy GTC's tissue and liquid biopsy testing for solid tumors and hematologic neoplasms in Germany. The collaboration expands molecular analysis for cancer diagnosis and therapy monitoring, with Labor Dr. Wisplinghoff joining GTC's Co-Op group for research and clinical trial access.Business Wire BlogLabor Dr. Wisplinghoff and Genomic Testing Cooperative (GTC) Partner to Deploy GTC’s Comprehensive Suite of Tissue and Liquid Biopsy Testing for Solid Tumor and Hematologic Neoplasms in GermanyLabor Dr. Wisplinghoff and Genomic Testing Cooperative (GTC) announced a partnership to deploy GTC's tissue and liquid biopsy testing for solid tumors and hematologic neoplasms in Germany. The collaboration expands Labor Dr. Wisplinghoff's analytical spectrum and provides physicians with deeper molecular insights for precision treatment. Labor Dr. Wisplinghoff will join GTC's Co-Op group for access to proprietary capabilities and clinical trials.PR NewswireLABOR DR. WISPLINGHOFF Y LABCONNECT SE UNEN PARA ACELERAR EL DESARROLLO DE MEDICAMENTOSLabor Dr. Wisplinghoff and LabConnect announced a strategic alliance to provide personalized central laboratory services across Europe to support global clinical trials. The partnership combines Wisplinghoff's extensive testing capabilities as one of Europe's largest independent medical laboratories with LabConnect's broad clinical trial services. LabConnect also announced the opening of a new facility in Swalmen, Netherlands for clinical kit building and biorepository storage, completing its EMEA infrastructure expansion.PR NewswireLABOR DR. WISPLINGHOFF UND LABCONNECT GEBEN STRATEGISCHE ALLIANZ BEKANNT - AUSBAU DER GLOBALEN ZENTRALEN LABORDIENSTLEISTUNGEN (CENTRAL LABRATORY SERVICES) ZUR BESCHLEUNIGUNG DER ARZNEIMITTELENTWICKLULabor Dr. Wisplinghoff and LabConnect announced a strategic alliance on May 31, 2023, to provide high-quality central laboratory services in Europe supporting global clinical trials. The partnership combines Wisplinghoff's extensive testing capabilities—one of Europe's largest independent medical laboratories—with LabConnect's comprehensive clinical trial services and 20+ years of experience. LabConnect also announced opening a new clinical kit manufacturing and biorepository storage facility in Swalmen, Netherlands, strengthening its EMEA infrastructure.PR NewswireLABOR DR. WISPLINGHOFF AND LABCONNECT ANNOUNCE STRATEGIC ALLIANCE - EXPANDING GLOBAL CENTRAL LABORATORY SERVICES TO ACCELERATE THE DEVELOPMENT OF MEDICINESLabor Dr. Wisplinghoff and LabConnect announced a strategic alliance to provide central laboratory services across Europe to support global clinical trials. The partnership combines Wisplinghoff's independent medical laboratory capabilities in Germany with LabConnect's clinical trial services and FSP solutions, while LabConnect simultaneously opened a new clinical kit building and biorepository storage facility in Swalmen, the Netherlands. The alliance positions both entities to offer pharmaceutical, biotech, and CRO clients a comprehensive range of services including lab kit production, logistics, sample management, testing, and integrated data management throughout Europe.PR NewswireEXPANDING GLOBAL CENTRAL LABORATORY SERVICES TO ACCELERATE THE DEVELOPMENT OF MEDICINESLabor Dr. Wisplinghoff and LabConnect announced a strategic alliance to provide central laboratory services in Europe for clinical trials. The partnership combines Wisplinghoff's testing capabilities with LabConnect's clinical trial support, and LabConnect also opened a new facility in Swalmen, Netherlands.